HRI provides tools to assess national harm reduction investment and spending on drug law enforcement in seven Asian countries and insights on the state of harm reduction financing by donors and governments, civil society and community representatives.
Tandon recounts how India's decision to impose a lockdown, forcing people who use drugs to go through withdrawals without treatment, can result in tragic deaths, highlighting the need for a policy change.
Gutierrez provides an analysis of how the participation of communities in the production of crops deemed illicit often represents a coping mechanism in relation to pre-existing forms of structural marginalisation, whilst exposing these communities to further vulnerabilities.
Whilst WHO member states aim to eliminate hepatitis C by 2030, interviews with 'at risk' individuals suggest that insufficient awareness of the illness and a lack of health facilities act as barriers to these ambitious targets.
Harm reduction workers in Afghanistan face an unjust paradox: Despite providing key support for people who use drugs and people living with HIV, they are often excluded from the public health community.